UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer’s Disease. Oxidative Medicine and Cellular Longevit Journal article
Oxidative Medicine and Cellular Longevity, 2022,Volume: 2022,Page: 21
Authors:  Qin Li;  Limor Rubin;  Marta Silva;  Shuai Li;  Chao Yang;  Philip Lazarovici;  Zheng WH(鄭文華)
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/08/30
Myricetin ameliorated prediabetes via immunomodulation and gut microbiota interaction Journal article
Food Frontiers, 2022
Authors:  Li Yang;  Yongchao Gao;  Jupeng Gong;  Hui Wang;  MohamedA. Farag;  JesusSimal-Gandara;  Yonghua Zhao;  Shaoping Nie;  Jianbo Xiao
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/07/31
Fecal Microbiota Transplantation  Immunomodulatory  Intestinal Microbiota  Myricetin  Predia-betes  
Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin Journal article
eFood, 2022,Volume: 3,Issue: e3
Authors:  Ruting ZHONG;  Mohamed A. Farag;  Meiwan Che;  Chengwei He;  Jianbo Xiao
Adobe PDF | Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/07/29
Bioactivities  Fisetin  Molecular Mechanism  Pharmacokinetics  Structure–activity Relationship  
Emerging pharmacotherapy for inflammatory bowel diseases Journal article
Pharmacological Research, 2022,Volume: 178
Authors:  Luo, Hua;  Cao, Guiqing;  Luo, Chun;  Tan, Dechao;  Vong, Chi Teng;  Xu, Yinyue;  Wang, Sicen;  Lu, Haitao;  Wang, Yitao;  Jing, Wanghui
Favorite |  | TC[WOS]:8 TC[Scopus]:8 | Submit date:2022/05/04
Emerging Pharmacotherapy  Ibd  Molecular Pathogenesis  Therapeutic Targets  
Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease Journal article
Biomedicine and Pharmacotherapy, 2021,Volume: 138
Authors:  Chen, Qiu Ling;  Yin, Hao Ran;  He, Qing Yu;  Wang, Ying
Favorite |  | TC[WOS]:8 TC[Scopus]:9 | Submit date:2021/12/08
Inflammatory Bowel Disease  Nlrp3  Small Molecule Inhibitor  Targeted Therapy  
Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials Journal article
Chinese Medicine, 2021,Volume: 16,Issue: 1
Authors:  Liang,Zuanji;  Chen,Xianwen;  Shi,Junnan;  Hu,Hao;  Xue,Yan;  Ung,Carolina Oi Lam
Favorite |  | TC[WOS]:9 TC[Scopus]:10 | Submit date:2021/03/01
Consort-chm  Non-alcoholic Fatty Liver Disease  Randomized Clinical Trial  Rct  Risk Of Bias  Traditional Chinese Medicine  
Efficacy and safety of traditional Chinese medicines for non‑alcoholic fatty liver disease: a systematic literature review of randomized controlled trials Journal article
Chinese Medicine, 2021,Page: 1-38
Authors:  Liang, Z.;  Chen, X.;  Shi, J.;  Hu, H.;  Xue, Y.;  Ung, O. L. C.
Favorite |  | TC[WOS]:9 TC[Scopus]:0 | Submit date:2022/07/27
Non-alcoholic Fatty Liver Disease  Traditional Chinese Medicine  Randomized Clinical Trial  Rct  Consortchm  Risk Of Bias